• LAST PRICE
    0.5246
  • TODAY'S CHANGE (%)
    Trending Down-0.0054 (-1.0134%)
  • Bid / Lots
    0.5220/ 1
  • Ask / Lots
    0.5250/ 213
  • Open / Previous Close
    0.5387 / 0.5300
  • Day Range
    Low 0.5214
    High 0.5458
  • 52 Week Range
    Low 0.5214
    High 20.3200
  • Volume
    782,379
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.53
TimeVolumeTNXP
09:32 ET138860.5301
09:34 ET214390.5302
09:36 ET40710.5302
09:38 ET90240.5303
09:39 ET6000.5347
09:41 ET8500.5347
09:43 ET120000.544
09:45 ET2100.5347
09:48 ET171020.54395
09:50 ET91000.54
09:52 ET208330.54
09:54 ET126840.54
09:56 ET110700.536099
09:57 ET110690.5371
09:59 ET23470.5385
10:01 ET116870.534201
10:03 ET25980.5388
10:06 ET52410.535
10:08 ET40430.5397
10:10 ET12050.5393
10:12 ET5000.535001
10:14 ET8000.5436
10:17 ET5000.5392
10:21 ET125080.5398
10:24 ET69000.54
10:26 ET6200.54
10:28 ET106000.53755
10:30 ET12000.5351
10:33 ET173630.54
10:35 ET8000.5356
10:37 ET6000.537799
10:39 ET95720.537799
10:42 ET47770.537999
10:44 ET236190.538
10:46 ET118410.5391
10:48 ET78300.5383
10:50 ET76500.5382
10:51 ET78000.5382
10:53 ET20000.5383
10:55 ET8230.5382
10:57 ET67000.5382
11:02 ET37000.5383
11:06 ET198360.5391
11:08 ET53860.539
11:09 ET23600.5384
11:13 ET104390.5385
11:15 ET72000.5384
11:20 ET10000.5384
11:22 ET9000.5384
11:24 ET73000.5379
11:26 ET34000.5378
11:27 ET10000.536017
11:29 ET60750.536
11:31 ET56350.5347
11:33 ET18000.534501
11:36 ET2200.5345
11:38 ET14000.5343
11:42 ET234660.534
11:44 ET7840.534099
11:45 ET73520.534015
11:47 ET9000.5341
11:49 ET90270.5339
11:51 ET9700.5339
11:56 ET10010.533801
11:58 ET18000.5338
12:00 ET160070.532
12:03 ET23500.53305
12:05 ET50000.5332
12:07 ET9760.5332
12:14 ET460490.5251
12:16 ET8620.5268
12:18 ET649060.5336
12:23 ET248240.5335
12:25 ET2000.53
12:30 ET8000.5253
12:32 ET16800.5299
12:34 ET57500.5299
12:36 ET5960.5296
12:38 ET6990.5282
12:39 ET8000.5225
12:41 ET11000.5246
12:43 ET2000.525
12:45 ET38000.5219
12:48 ET17740.5281
12:50 ET1770.5268
12:52 ET16000.5266
12:54 ET2000.5266
12:56 ET64000.5227
12:57 ET9910.5241
12:59 ET12860.5241
01:01 ET31850.5227
01:03 ET9000.5227
01:06 ET6900.5214
01:08 ET1000.52495
01:10 ET59800.5233
01:12 ET7000.525
01:14 ET8000.5217
01:17 ET48080.5233
01:21 ET15460.524849
01:24 ET19000.52505
01:26 ET8000.5219
01:30 ET12030.5251
01:32 ET10000.52505
01:33 ET5820.522
01:37 ET8000.5219
01:42 ET8000.52505
01:44 ET58000.5219
01:46 ET1000.5268
01:48 ET5000.5235
01:50 ET7000.5219
01:51 ET103000.52505
01:53 ET78000.522
01:55 ET159990.525
01:57 ET142550.522
02:00 ET164010.5234
02:02 ET135360.5234
02:04 ET29000.522
02:06 ET20500.524629
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTNXP
Tonix Pharmaceuticals Holding Corp
23.4M
-0.1x
---
United StatesGRCL
Gracell Biotechnologies Inc
165.1M
-2.1x
---
United StatesELEV
Elevation Oncology Inc
26.5M
-0.4x
---
United StatesRGLS
Regulus Therapeutics Inc
24.6M
-0.7x
---
United StatesFWP
Forward Pharma A/S
21.9M
-11.1x
---
United StatesMITO
Stealth BioTherapeutics Corp
22.7M
-0.3x
---
As of 2022-09-27

Company Information

Tonix Pharmaceuticals Holding Corp. (Tonix) is a clinical-stage biopharmaceutical company. It is focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonixs portfolio is primarily composed of immunology and central nervous system (CNS) and infectious disease product candidates. Its immunology portfolio includes biologics to address organ transplant rejection, autoimmune diseases, and cancer. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Its infectious disease portfolio of product candidates includes vaccines to prevent COVID-19, an antiviral to treat COVID-19, and treatment for long COVID. The infectious disease portfolio also includes a vaccine in development to prevent smallpox and monkeypox. Its product candidates include TNX-1500, TNX-1300, TNX-102 SL, TNX-102 SL, TNX-102 SL,TNX-1900,TNX-601 CR, and TNX-1900.

Contact Information

Headquarters
26 Main Street, Suite 101CHATHAM, NJ, United States 07928
Phone
212-980-9155
Fax
212-923-5700

Executives

Chairman of the Board, President, Chief Executive Officer
Seth Lederman
Chief Financial Officer, Treasurer
Bradley Saenger
Chief Operating Officer
Jessica Morris
Secretary, Chief Medical Officer
Gregory Sullivan
Lead Independent Director
James Treco

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$23.4M
Revenue (TTM)
$0.00
Shares Outstanding
44.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.73
EPS
$-6.55
Book Value
$14.10
P/E Ratio
-0.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.